Table 1 Descriptive summary of the included studies in the rapid review
Characteristics | Categories | Number (n); Proportion (%) | References |
|---|---|---|---|
Date of Publication | 2011–2015 | n = 3; 12% | Hillyer et al. 2011; Hillyer et al. 2014; Turrin et al. 2015 |
2016–2020 | n = 12; 48% | Bartholomew et al. 2019; Christy et al. 2016; Clarke et al. 2016; Crosby et al. 2017; Davis et al. 2016; Hirko et al. 2020; Lee et al. 2020; Sali et al. 2016; Sali et al. 2018; Somsouk et al. 2019; Stone et al. 2019; Symonds et al. 2019 | |
2021–2022 | n = 10; 40% | Botteri et al. 2022; De Klerk et al. 2022; Gomes et al. 2021; Gupta et al. 2022; Lee et al. 2022; Lucas et al. 2021; Prakash et al. 2022; Ritzenthaler et al. 2022; Van der Meulen et al. 2022; Young et al. 2021 | |
Location | United States | n = 14; 56% | Christy et al. 2016; Crosby et al. 2017; Davis et al. 2016; Gupta et al. 2022; Hillyer et al. 2011; Hillyer et al. 2014; Hirko et al. 2020; Lee et al. 2020; Lee et al. 2022; Lucas et al. 2021; Prakash et al. 2022; Ritzenthaler et al. 2022; Somsouk et al. 2020; Stone et al. 2019 |
Italy | n = 3; 12% | Sali et al. 2016; Sali et al. 2018; Turrin et al. 2015 | |
Netherlands | n = 2; 8% | De Klerk et al. 2022; Van der Meulen et al. 2022 | |
Australia | n = 2; 8% | Symonds et al. 2019; Young et al. 2021 | |
Other | n = 4; 16% | Bartholomew et al. 2019; Botteri et al. 2022; Clarke et al. 2016; Gomes et al. 2021 | |
Study Designa | Randomized controlled trials (with or without two arms) and controlled clinical trials | n = 14; 56% | Bartholomew et al. 2019; Botteri et al. 2022; Christy et al. 2016; Davis et al. 2017; Gupta et al. 2013; Hirko et al. 2020; Lee et al. 2020; Lee et al. 2022; Prakash et al. 2022; Sali et al. 2016; Sali et al. 2018; Somsouk et al. 2020; Symonds et al. 2019; Young et al. 2021 |
Cohort (e.g., cohort: one group pre + post; cohort analytic: intervention and comparison group pre and post) | n = 4; 16% | Crosby et al. 2017; Hillyer et al. 2011; Ritzenthaler et al. 2022; Stone et al. 2019 | |
Ecological studies | n = 3; 12% | Clarke et al. 2016; de Klerk et al. 2022; Van der Meulen et al. 2022 | |
Cross-sectional studies | n = 2; 8% | Gomes et al. 2021; Turrin et al. 2015 | |
Other (e.g., retrospective record review) | n = 2; 8% | Hillyer et al. 2014; Lucas et al. 2021 | |
Access to Healthcare Provider or Healthcare System | No access to regular healthcare provider (based on stratified data analysis) | n = 5; 20% | Crosby et al. 2017; Christy et al. 2016; Davis et al. 2017; Gomes et al. 2021; Stone et al. 2019 |
No or precarious access to the healthcare system | n = 17; 68% | Bartholomew et al. 2019; Botteri et al. 2022; Gupta et al. 2013; Hirko et al. 2020; Hillyer et al. 2011; Hillyer et al. 2014; Lee et al. 2020; Lucas et al. 2022; Prakash et al. 2022; Ritzenthaler et al. 2022; Lee et al. 2022; Sali et al. 2016; Sali et al. 2018; Somsouk et al. 2022; Symonds et al. 2019; Turrin et al. 2015; Young et al. 2021 | |
Access to healthcare system not specified but results divided by SESb | n = 3; 12% | Clarke et al. 2016; de Klerk et al. 2022; Van der Meulen et al. 2022 | |
Method of FIT Delivery | In-person | n = 10; 40% | Christy et al. 2016; Crosby et al. 2017; Davis et al. 2017; Gomes et al. 2021; Hillyer et al. 2011; Hillyer et al. 2014; Prakash et al. 2022; Sali et al., 2016; Sali et al. 2018; Stone et al. 2019 |
By mail | n = 13; 52% | Bartholomew et al. 2019; Botteri et al. 2022; Clarke et al. 2016; Gupta et al. 2013; Hirko et al. 2020; Lee et al. 2022; Lee et al. 2020; Lucas et al. 2021; Ritzenthaler et al. 2022; Somsouk et al. 2022; Van der Meulen et al. 2022; Symonds et al., 2019; Young et al. 2021 | |
Unclear | n = 2; 8% | De Klerk et al. 2022; Turrin et al. 2015 | |
Method of FIT Return | In-person | n = 3; 12% | Crosby et al. 2017; Sali et al.2016; Sali et al. 2018 |
By mail | n = 12; 48% | Botteri et al. 2022; Christy et al. 2016; Davis et al. 2017; Gupta et al. 2013; Hirko et al. 2020; Lucas et al. 2022; Prakash et al. 2022; Ritzenthaler et al. 2022; Somsouk et al. 2022; Stone et al. 2019; Symonds et al. 2019; Young et al. 2021 | |
In-person or by mail | n = 3; 12% | Hillyer et al. 2011; Hillyer et al. 2014; Lee et al. 2022 | |
Unclear | n = 7; 28% | Bartholomew et al. 2019; Clarke et al. 2016; De Klerk et al. 2022; Gomes et al. 2021; Lee et al. 2020; Turrin et al. 2015; Van der Meulen et al. 2022 |